Related Experiment Videos
Nontyphoidal salmonellosis
1Infectious Diseases Division, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA. ehohmann@partners.org
Summary
Nontyphoidal Salmonella infections pose significant risks, especially to immunocompromised individuals. Emerging antibiotic resistance in Salmonella presents future therapeutic challenges for clinicians.
Area of Science:
- Infectious Diseases
- Microbiology
- Foodborne Pathogens
Background:
- Nontyphoidal Salmonella are significant foodborne pathogens causing gastroenteritis and systemic infections.
- Immunocompromised individuals, including those with malignancy, HIV, diabetes, or on immunosuppressive therapy, are at higher risk.
- Complications include endovascular infections and deep abscesses, posing treatment challenges.
Purpose of the Study:
- To provide an overview of current problems and emerging trends in nontyphoidal Salmonella infections.
- To highlight challenges in treating infections in immunocompromised hosts.
- To address the growing concern of antimicrobial resistance.
Main Methods:
- Literature review and clinical overview.
- Analysis of epidemiological trends and clinical manifestations.
- Discussion of treatment considerations and resistance patterns.
Main Results:
- Nontyphoidal Salmonella infections are particularly severe in immunocompromised populations.
- Difficult-to-treat complications such as endovascular infections and abscesses are noted.
- Emerging resistance to fluoroquinolones and third-generation cephalosporins is a significant concern.
Conclusions:
- Salmonellosis management requires careful consideration of host immune status and infection site.
- Antimicrobial resistance in nontyphoidal Salmonella is an increasing threat to effective treatment.
- Infectious disease clinicians must stay informed about evolving challenges in salmonellosis therapy.